COMPARE · Data as of August 21, 2026
PACS vs UHS
Verdict: Side-by-side breakdown using the Bull Rankings model. PACS scored 70.7, UHS scored 69.1 — PACS leads.
Compare another set
PACS
PACS Group, Inc.
70.7
$44.25 · $7.0B
fundamentals as of
Score gap
1.6
PACS leads
UHS
Universal Health Services, Inc.
69.1
$177.26 · $10.4B
fundamentals as of
At a glance · who leads each dimension, on the model's own rules
- CheapestUHS7.2x
- Fastest growthPACS+15.2%
- Strongest balance sheetUHS0.69
- Highest qualityUHS68 / 100
- Largest discount to fair valueUHS-19%
Side by side · every name on one set of axes
Growth against the P/E multiple. Up and to the right is cheaper and faster — the quality-growth idea in one picture. Points beyond the axis are pinned to the edge and marked off-scale rather than allowed to compress everything else.
The model, pillar by pillar (0–100 each)
PACS
stronger →← stronger
UHS
63
Qualityreturns · margins · balance sheet
68
90
Growthrevenue & earnings expansion
59
63
Valuevaluation vs sector peers
82
UHS is stronger on 2 of 3 pillars.
Fundamentals, head-to-head
PACS
UHS
$121mC
FCF
$845mC+
+15.2%B+
Rev
+10.0%B
3.05D
D/E
0.69C+
25.9xB
P/E
7.2xA
1.19B+
PEG
1.25B
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
Valuation · DCF cross-check
PACS
UHS
252% above
Price vs fair valuelower is cheaper
19% below
~38%/yr
Growth the price implies10-yr FCF · lower = less priced in
~0%/yr
-73%
1-yr DCF upside
+17%
-72%
5-yr DCF upside
+23%
-69%
10-yr DCF upside
+32%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
Model signals
PACS
Why this score
- Short track record
UHS
Why this score
- Buying back stock
The companies
PACSPACS Group, Inc.
Why now
Medical Care Facilities · market cap $7.0b. 11% off the 52-week high of $49.49. Revenue growing +15%, comfortably above the S&P median. 5 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $59.20 (implying +34% upside).
Moat
ROE 24% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately.
Risk
D/E 3.05 is elevated — limits strategic flexibility and raises refinancing exposure if rates stay higher for longer. Net margin 4.9% is thin — operating leverage cuts both ways; input-cost inflation or pricing pressure hits the bottom line first.
UHSUniversal Health Services, Inc.
Why now
Medical Care Facilities · market cap $10.4b. Down 28% from 52-week high of $246.33 — deep drawdown territory. Revenue growing +10%, comfortably above the S&P median. 17 sell-side analysts rate this a Buy with a mean 1-yr target of $193.94 (implying +9% upside).
Moat
ROE 20% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately.
Risk
Value re-rating depends on a catalyst. Without one — analyst day, divestiture, margin recovery, capital return — the stock can stay cheap on these multiples for years.
Verdict — model-derived comparison
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.
Where PACS and UHS diverge
On the headline score the gap is 1.6 points in favor of PACS. They get there differently, though — each leads on a different pillar, so the better pick depends on which you weight.
- GrowthPACS 89.7 · UHS 58.6PACS +31.1
- ValuePACS 62.7 · UHS 82.2UHS +19.5
- QualityPACS 62.8 · UHS 68.4UHS +5.6
Pillars run 0–100 against sector peers, so a score is a statement about a company relative to its own industry rather than to the other name here. A wide Value gap usually means the market already prices the difference in quality or growth — which is the trade-off this comparison comes down to.